Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Solifenacin Succinate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,423Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jubilant`s Generics Solifenacin Receives Tentative Approval in US
    Jubilant`s Generics Solifenacin Receives Tentative Approval in US

    02 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205484

    FDA
    02 Oct 2024
    Share Share
    Lannett's Generic Solifenacin Succinate Receives Approval in the U.S.
    Lannett's Generic Solifenacin Succinate Receives Approval in the U.S.

    06 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211622

    FDA
    06 Jun 2023
    Share Share
    Aurobindo's Generic Sildenafil Citrate Receives Approval in the U.S.
    Aurobindo's Generic Sildenafil Citrate Receives Approval in the U.S.

    27 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206817

    FDA
    27 Dec 2022
    Share Share
    Annora Pharma's Generic Solifenacin Succinate Receives Approval in the U.S.
    Annora Pharma's Generic Solifenacin Succinate Receives Approval in the U.S.

    15 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215761

    FDA
    15 Jun 2022
    Share Share
    Accord Healthcare's Generic Solifenacin Succinate Receives Approval in the U.S.
    Accord Healthcare's Generic Solifenacin Succinate Receives Approval in the U.S.

    04 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207477

    FDA
    04 Jan 2022
    Share Share
    Cipla recalls 7,228 bottles of overactive bladder treatment drug in America
    Cipla recalls 7,228 bottles of overactive bladder treatment drug in America

    25 Jul 2021

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/cipla-recalls-7228-bottles-of-overactive-bladder-treatment-drug-in-america/articleshow/84725538.cms?from=mdr

    ECONOMIC TIMES
    25 Jul 2021
    Share Share